Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
Dr. David McDermott Harvard Medical School, USA1 Talk
Dr. McDermott is the Leader of the Dana Farber/Harvard Cancer Center (DF/HCC) Kidney Cancer Program and an Associate Professor of Medicine at Harvard Medical School. He is the co-Principal Investigator of the only National Cancer Institute, Specialized Programs of Research Excellence (SPORE) grant to focus on kidney cancer and an... read moreinternational leader in the biologic therapy of cancer, with a focus on melanoma and kidney cancer management. His immunotherapy research has focused on approaches to improve the therapeutic index of interleukin-2, developing “targeted” immunotherapies and rational combination approaches for patients with solid tumors.